KYORIN Pharmaceutical Co., Ltd. (TYO:4569)

KYORIN Pharmaceutical Ratios and Metrics

Market cap in millions JPY. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan 20, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	92,267	86,288	104,097	97,646	101,826	110,478
Market Cap Growth	10.99%	-17.11%	6.61%	-4.11%	-7.83%	-12.26%
Enterprise Value	99,571	103,362	105,733	99,919	92,413	99,268
Last Close Price	1606.00	1482.33	1724.19	1576.37	1594.96	1682.30
PE Ratio	9.89	9.50	19.56	20.68	25.90	18.02
Forward PE	19.85	20.70	17.98	18.11	30.61	18.49
PS Ratio	0.69	0.66	0.87	0.86	0.97	1.07
PB Ratio	0.68	0.63	0.80	0.78	0.82	0.89
P/TBV Ratio	0.70	0.66	0.83	0.81	0.84	0.91
P/FCF Ratio	27.31	-	-	-	26.10	98.47
P/OCF Ratio	14.61	24.61	67.20	48.63	16.05	21.29
PEG Ratio	-	9.56	9.56	9.56	9.56	9.56
EV/Sales Ratio	0.74	0.80	0.89	0.88	0.88	0.97
EV/EBITDA Ratio	5.88	6.03	10.27	11.15	10.60	10.63
EV/EBIT Ratio	8.05	8.24	17.61	19.51	18.47	17.19
EV/FCF Ratio	29.47	-	-	-	23.68	88.48
Debt / Equity Ratio	0.16	0.21	0.16	0.17	0.17	0.18
Debt / EBITDA Ratio	1.33	1.66	2.03	2.37	2.48	2.34
Debt / FCF Ratio	6.64	-	-	-	5.54	19.50
Asset Turnover	0.73	0.70	0.68	0.65	0.62	0.61
Inventory Turnover	1.10	1.18	1.34	1.40	1.39	1.43
Quick Ratio	1.91	1.82	1.36	1.91	2.15	2.60
Current Ratio	4.70	3.88	2.62	3.40	3.62	4.16
Return on Equity (ROE)	7.00%	6.80%	4.15%	3.78%	3.16%	4.96%
Return on Assets (ROA)	4.22%	4.22%	2.12%	1.84%	1.85%	2.13%
Return on Invested Capital (ROIC)	6.13%	6.24%	3.44%	2.85%	3.22%	3.70%
Return on Capital Employed (ROCE)	7.80%	7.90%	4.50%	3.60%	3.60%	4.10%
Earnings Yield	10.11%	10.53%	5.11%	4.84%	3.86%	5.55%
FCF Yield	3.66%	-2.54%	-4.06%	-4.43%	3.83%	1.02%
Dividend Yield	3.55%	3.51%	3.02%	3.30%	3.26%	4.46%
Payout Ratio	35.41%	33.18%	56.61%	63.84%	95.80%	70.91%
Buyback Yield / Dilution	-	-0.10%	-0.15%	-0.00%	-0.01%	-0.02%
Total Shareholder Return	3.54%	3.40%	2.86%	3.30%	3.25%	4.44%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.